Singapore markets closed

Reckitt Benckiser Group plc (RKT.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
4,486.00+107.00 (+2.44%)
At close: 04:36PM BST
Full screen
Previous close4,379.00
Open4,363.00
Bid4,493.00 x N/A
Ask4,494.00 x N/A
Day's range4,362.00 - 4,511.00
52-week range4,102.64 - 6,006.00
Volume1,646,585
Avg. volume2,395,425
Market cap31.313B
Beta (5Y monthly)0.09
PE ratio (TTM)20.67
EPS (TTM)2.17
Earnings date24 Jul 2024
Forward dividend & yield1.96 (4.48%)
Ex-dividend date01 Aug 2024
1y target est5,441.88
  • The Telegraph

    Cillit Bang to be sold after 20 years

    Cillit Bang, the cleaning brand known for its adverts featuring character Barry Scott, is to be sold off by its parent company after 20 years.

  • Reuters

    Reckitt to offload homecare brands, consider nutrition options

    Reckitt Benckiser will consider options for its troubled nutrition business and offload a portfolio of homecare brands by the end of 2025, it said on Wednesday, planning to refocus on healthcare and hygiene. Reckitt's home care portfolio, which includes Air Wick air fresheners and Cillit Bang cleaner, achieved sales of around 1.9 billion pounds ($2.5 billion) last year, but the company no longer considers it a core business. The British consumer goods firm had also been under pressure from shareholders to consider a sale of its Mead Johnson nutrition business, which sells baby formula products.

  • Reuters

    Reckitt pressed by shareholders to revisit sale of nutrition business, FT reports

    Reckitt acquired U.S. baby formula maker Mead Johnson Nutrition for $16.6 billion in 2017, but is currently seeking to overturn a $60 million verdict in a lawsuit after a jury ordered the unit to pay the mother of a premature baby who died of an intestinal disease after being fed the Enfamil baby formula. The company has said it faces "contingent liabilities" - a term used for those dependent on future events - from the product liability suit filed against Mead Johnson in the United States. Portfolio managers at Reckitt's third largest shareholder Flossbach von Storch, and Causeway Capital Management, a top-10 shareholder, told the FT that they would be open to seeing Reckitt sell the unit.